iShares Global Tech ETF vs Mesoblast Limited — how do they compare? iShares Global Tech ETF trades at $140.02, while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: iShares Global Tech ETF is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.
| IXN | MESO | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $149.74 | $20.96 |
52-Week Low | $94.42 | $12.88 |
Market Cap | — | $2.21B |
Enterprise Value | — | $2.21B |
Trailing returns across standard periods
IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.
Read more on IXN →Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →